close

Log in

Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.

Forgot Your Password?

Don't have an account? Sign up

This site is intended for Healthcare Professionals only

module menu icon

Key practice developments of 2017

New medicines
New medicines continued
What's new?
Safety issues
Safety issues 2
Safety issues 3
Safety issues 4
Menopause Quality Standard
Assessment questions

module menu icon Menopause Quality Standard

Keep going!  (0% complete)

quiz close icon

module menu icon Menopause Quality Standard

NICE’s newly published Quality Standard on the menopause highlighted several areas that community pharmacy can support, particularly:

  • The fact that diagnostic tests are not required for women aged over 45 years with menopausal symptoms
  • The significance of providing information on menopausal symptoms to women who undergo surgical or medical treatment that may induce the condition
  • The need to offer hormone replacement therapy (HRT) or a combined oral contraceptive to women with premature ovarian insufficiency as failure to do so can reduce quality of life and increase the risk of osteoporosis and cardiovascular disease
  • The importance of reviewing women three months after starting any treatment and then at least annually thereafter.
    • Change privacy settings